Skip to main content

Table 3 Comparison of pathological findings between groups according to cancer recurrence and survival states

From: Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study

Pathology

Recurrence

Death

Yes

No

P

Yes

No

P

N = 42

N = 113

N = 21

N = 134

Per-op CCRTx

  

0.912

  

0.065

(+)

7(16.7)

18(15.9)

 

0(0.0)

25((18.7)

 

(−)

35(83.3)

95(84.1)

 

21(100)

109(81.3)

 

T stage

  

0.769

  

0.783

T1

5(11.9)

9(8.0)

 

2(9.5)

12(9.0)

 

T2

7(16.7)

18(15.2)

 

3(14.3)

22(16.4)

 

T3

15(35.7)

49(43.4)

 

7(33.3)

57(42.5)

 

T4

15(35.7)

37(32.7)

 

9(42.9)

43(32.1)

 

N stage

  

0.590

  

0.246

N0

21(50.0)

59(52.2)

 

9(42.9)

71(53.0)

 

N1

12(28.6)

24(21.2)

 

8(38.1)

28(20.9)

 

N2

9(21.4)

30(26.5)

 

4(19.0)

35(26.1)

 

M stage

  

0.385

  

0.356

M0

40(95.2)

104(92.0)

 

18(85.7)

126(94.0)

 

M1

2(4.8)

9(8.0)

 

3(14.3)

8(6.0)

 

TNM stage

  

0.867

  

0.321

I

8(19.0)

19(16.8)

 

2(9.5)

25(18.7)

 

II

12(28.6)

38(33.6)

 

6(28.6)

44(32.8)

 

III

20(47.6)

48(42.5)

 

10(47.6)

58(43.3)

 

IV

2(4.8)

8(7.1)

 

3(14.3)

7(5.2)

 

Pos-op CCRTx

  

0.830

  

0.204

(+)

20(47.6)

56(49.6)

 

8(38.1)

71(53.0)

 

(−)

22(52.4)

57(50.4)

 

13(61.9)

63(47.0)

 
  1. *Significant P values
  2. CCRTx chemoradiation therapy, TNM tumor-node-metastasis